|
Combined promoter methylation detection of free-circulating tumor-associated DNA in colorectal cancer
演題番号 : FP3-4
Speaker）Weiwei Tang:1,2、Hanxiang An:1、Dan Zhou:3、Lilin Chen:1、Mingquan Cai:1、Feng Ye:1、Yun Zhang:4,5
1:Department of Medical Oncology, Xiamen Cancer Hospital, The First Affiliated Hospital of Xiamen University, China、2:Department of Oncology, Fujian Medical University, China、3:Xiang'an Hospital of Xiamen University, China、4:Key Laboratory of Design and Assembly of Functional Nanostructures, Fujian Provincial Key Laboratory of Nanomaterials, Fujian Institute of Research on the Structure of Matter, Chinese Academy of Sciences, China、5:Xiamen Institute of Rare Earth Materials, Chinese Academy of Sciences, China
|
|
|
|
PI3K/AKT activation induce Ibrutinib resistance in chronic lymphocytic leukemia
演題番号 : FP3-20
Speaker）Li Yue:1,2、Kapoor Isha:2、Zhu Huayuan:1、Hill Brian:3、Li Jianyong:1、Xu Wei:1、Almasan Alexandru:2
1:Jiangsu Province Hospital, the First Affiliated Hospital of Nanjing Medical University, China、2:Department of Cancer Biology, Cleveland Clinic, Lerner Research Institute, USA、3:Department of Hematology and Oncology, Cleveland Clinic, Taussig Cancer Center, China
|
|
|
|
T-cell receptor signaling pathway, a novel candidate therapeutic target for the treatment of AITL.
演題番号 : FP3-23
Speaker）Yalu Liu:1、Ning Ding:1、Yuqin Song:1、Xiaogan Wang:1、Lijuan Deng:1、Lingyan Ping:1、Yunfei Shi:2、Wen Zheng:1、Ningjing Lin:1、Xiaopei Wang:1、Meifeng Tu:1,2、Yan Xie:1、Zhengying Pan:3、Xi Wang:4、Jun Zhu:1
1:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Lymphoma, Peking University Cancer Hospital & Institute, China、2:Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Pathology, Peking University Cancer Hospital & Institute, China、3:Key Laboratory of Chemical Genomics, Department of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, China、4:Laboratory of Immunology, Department of Immunology, Capital Medical University, China
|
|
|
|
Universal screening for Lynch Syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features
演題番号 : FP3-32
Speaker）Wu Jiang:1、Peirong Ding:1、Muyan Cai:2、Shiyong Li:3、Jinxin Bei:4、Fang Wang:5、Jibin Li:6、Zhizhong Pan:1
1:Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, China、2:Department of Pathology, Sun Yat-sen University Cancer Center, China、3:BGI-Guangzhou Medical Laboratory, BGI-Shenzhen, China、4:Department of Experimental Research, Sun Yat-sen University Cancer Center, China、5:Department of Molecular Diagnostics, Sun Yat-sen University Cancer Center, China、6:Department of Clinical Research, Sun Yat-Sen University Cancer Center, China
|
|
|
|
